APA (7th ed.) Citation

RJ, V., JS, d. G., BO, F., MN, H., AM, M., & KPM, S. (2025). Reply to: Peak Corticosteroid Dose for Immune-Related Adverse Events and Survival: Not the Whole Story. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 43(5), 616. https://doi.org/10.1200/JCO-24-02234

Chicago Style (17th ed.) Citation

RJ, Verheijden, de Groot JS, Fabriek BO, Hew MN, May AM, and Suijkerbuijk KPM. "Reply to: Peak Corticosteroid Dose for Immune-Related Adverse Events and Survival: Not the Whole Story." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 43, no. 5 (2025): 616. https://doi.org/10.1200/JCO-24-02234.

MLA (9th ed.) Citation

RJ, Verheijden, et al. "Reply to: Peak Corticosteroid Dose for Immune-Related Adverse Events and Survival: Not the Whole Story." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 43, no. 5, 2025, p. 616, https://doi.org/10.1200/JCO-24-02234.